190 filings
Page 6 of 10
S-8
gmb dx5au1gjq0mb
25 Feb 20
Registration of securities for employees
4:22pm
8-K
dw2ha d1kcuval
25 Feb 20
Evolus Reports Fourth Quarter and Full Year 2019 Results and Provides Business Update
7:01am
8-K
lln6ma1hyd3rj6dt9
10 Jan 20
Regulation FD Disclosure
8:25am
8-K
8y574mxahhjx6wvig
9 Jan 20
Evolus Announces Preliminary Unaudited Fourth Quarter and Full Year 2019 Revenue
9:01am
8-K
x1pv4v
12 Nov 19
Entry into a Material Definitive Agreement
4:16pm
424B5
xvjlmqwne91
7 Nov 19
Prospectus supplement for primary offering
5:07pm
424B5
s96h04 yvk0
6 Nov 19
Prospectus supplement for primary offering
4:04pm
8-K
d71ydw8vew
4 Nov 19
Evolus Reports Third Quarter 2019 Financial Results and Provides Business Update
7:01am
UPLOAD
2u0kj oc05
20 Sep 19
Letter from SEC
12:00am
8-K
25y7uxul29nh ndtdc
12 Aug 19
Evolus Reports Second Quarter 2019 Financial Results
7:02am
CORRESP
atc3 l66bz
12 Aug 19
Correspondence with SEC
12:00am
UPLOAD
rswv4m 6ppmh7
6 Aug 19
Letter from SEC
12:00am
8-K
1x9jx 8yz
16 Jul 19
Evolus Expands Board of Directors with Appointment of Independent Directors
4:47pm
8-K
gzdddu2d
12 Jun 19
Submission of Matters to a Vote of Security Holders
9:14am
8-K
amhuyu
10 Jun 19
Evolus Provides Update on Nuceiva™ Marketing Authorization Application in Europe
9:49am